95 related articles for article (PubMed ID: 8115415)
1. Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves.
Drucker GE; Ritzmann RF; Wichlinski LJ; Engh K; Gordon JH; Fields JZ
Pharmacol Biochem Behav; 1994 Jan; 47(1):141-5. PubMed ID: 8115415
[TBL] [Abstract][Full Text] [Related]
2. The effects of cyclo(leucyl-glycyl) on nigrostriatal dopaminergic supersensitivity--inhibition of apomorphine-induced climbing.
Fields JZ; Lee JM; Gordon JH; Wichlinski LJ; Ritzmann RF
Neuropeptides; 1990 Aug; 16(4):207-11. PubMed ID: 2274115
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity.
Fields JZ; Wichlinski L; Drucker GE; Engh K; Gordon JH
Pharmacol Biochem Behav; 1991 Dec; 40(4):881-6. PubMed ID: 1816575
[TBL] [Abstract][Full Text] [Related]
4. Radio-frequency analysis of the effect of haloperidol and cyclo (leucyl-glycyl) on apomorphine-induced stereotypy.
Fields JZ; Gonzalez LP; Meyerson LR; Lieber P; Lee JM; Steece KA; DeLeon-Jones FA; Ritzmann RF
Pharmacol Biochem Behav; 1986 Dec; 25(6):1279-84. PubMed ID: 3809231
[TBL] [Abstract][Full Text] [Related]
5. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine.
Lee JM; DeLeon-Jones F; Fields JZ; Ritzmann RF
Alcohol Drug Res; 1987; 7(1):1-10. PubMed ID: 2431697
[TBL] [Abstract][Full Text] [Related]
6. Cyclo (Leu-Gly) + haloperidol: effects on dopamine receptors and conditioned avoidance responding.
Bean AJ; Elgin RJ; Cooper DM; Martin GE
Peptides; 1987; 8(1):39-44. PubMed ID: 3575153
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
Bhargava HN
Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
[TBL] [Abstract][Full Text] [Related]
8. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding.
Pierce RC; Rowlett JK; Bardo MT; Rebec GV
Neuroscience; 1991; 45(2):373-8. PubMed ID: 1762684
[TBL] [Abstract][Full Text] [Related]
9. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
Marin C; Parashos SA; Kapitzoglou-Logothetis V; Peppe A; Chase TN
Pharmacol Biochem Behav; 1993 May; 45(1):195-200. PubMed ID: 8516358
[TBL] [Abstract][Full Text] [Related]
10. Cyclo(Leu-Gly) has opposite effects on D-2 dopamine receptors in different brain areas.
Lee JM; Ritzmann RF; Fields JZ
Peptides; 1984; 5(1):7-10. PubMed ID: 6231532
[TBL] [Abstract][Full Text] [Related]
11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
12. Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat.
Fields JZ; Gordon JH
Brain Res Bull; 1991 Apr; 26(4):549-52. PubMed ID: 1831063
[TBL] [Abstract][Full Text] [Related]
13. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
Prosser ES; Pruthi R; Csernansky JG
Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
[TBL] [Abstract][Full Text] [Related]
14. Ethanol reduces tolerance, sensitization, and up-regulation of D2-receptors after subchronic haloperidol.
Wolffgramm J; Rommelspacher H; Buck E
Pharmacol Biochem Behav; 1990 Aug; 36(4):907-14. PubMed ID: 2217521
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).
Rajakumar G; Naas F; Johnson RL; Chiu S; Yu KL; Mishra RK
Peptides; 1987; 8(5):855-61. PubMed ID: 2893360
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
17. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
Schröder U; Schröder H; Augustin W; Sabel BA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425
[TBL] [Abstract][Full Text] [Related]
18. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states.
LaHoste GJ; Wigal T; King BH; Schuck SEB; Crinella FM; Swanson JM
Exp Clin Psychopharmacol; 2000 Feb; 8(1):125-132. PubMed ID: 10743913
[TBL] [Abstract][Full Text] [Related]
20. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
Meller E
Psychopharmacology (Berl); 1982; 76(3):222-7. PubMed ID: 6808540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
